Medicure Ebitda from 2010 to 2024
| MPH Stock | CAD 0.90 0.02 2.27% |
EBITDA | First Reported 2002-06-30 | Previous Quarter 582 K | Current Value -556 K | Quarterly Volatility 4.9 M |
Check Medicure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Total Revenue of 11.8 M or Gross Profit of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0 or PTB Ratio of 0.46. Medicure financial statements analysis is a perfect complement when working with Medicure Valuation or Volatility modules.
Medicure | Ebitda |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.